Cargando…
Reduced levels of alpha-1-antitrypsin in cerebrospinal fluid of amyotrophic lateral sclerosis patients: a novel approach for a potential treatment
BACKGROUND: Amyotrophic lateral sclerosis (ALS) is an incurable neurodegenerative motor neuron disease that involves activation of the immune system and inflammatory response in the nervous system. Reduced level of the immuno-modulatory and anti-inflammatory protein alpha-1-antitrypsin (AAT) is asso...
Autores principales: | Wormser, Uri, Mandrioli, Jessica, Vinceti, Marco, Fini, Nicola, Sintov, Amnon, Brodsky, Berta, Proskura, Elena, Finkelstein, Yoram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888657/ https://www.ncbi.nlm.nih.gov/pubmed/27245439 http://dx.doi.org/10.1186/s12974-016-0589-4 |
Ejemplares similares
-
Interplay of Metallome and Metabolome in Amyotrophic
Lateral Sclerosis: A Study on Cerebrospinal Fluid of Patients Carrying
Disease-Related Gene Mutations
por: Solovyev, Nikolay, et al.
Publicado: (2023) -
Selenoprotein P Concentrations in the Cerebrospinal Fluid and Serum of Individuals Affected by Amyotrophic Lateral Sclerosis, Mild Cognitive Impairment and Alzheimer’s Dementia
por: Urbano, Teresa, et al.
Publicado: (2022) -
Proteomic analysis of cerebrospinal fluid in amyotrophic lateral sclerosis
por: CHEN, YAN, et al.
Publicado: (2016) -
Cerebrospinal Fluid Chitinases as Biomarkers for Amyotrophic Lateral Sclerosis
por: Costa, Júlia, et al.
Publicado: (2021) -
Biomarkers in cerebrospinal fluid for amyotrophic lateral sclerosis phenotypes
por: Zhou, Jinxia, et al.
Publicado: (2023)